Leishmaniases as Re-emerging Diseases / / edited by Farhat Afrin and Hassan Hemeg.
Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furth...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | London, United Kingdom : : IntechOpen,, 2018. |
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 online resource (viii, 222) :; illlustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545327804498 |
---|---|
ctrlnum |
(CKB)4970000000100252 (NjHacI)994970000000100252 (oapen)https://directory.doabooks.org/handle/20.500.12854/51562 (EXLCZ)994970000000100252 |
collection |
bib_alma |
record_format |
marc |
spelling |
Hassan Hemeg auth Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg. IntechOpen 2018 London, United Kingdom : IntechOpen, 2018. 1 online resource (viii, 222) : illlustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (Intech, viewed October 13, 2022). Includes bibliographical references. Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furthermore, to strengthen the leishmaniasis elimination drive, particular emphasis has to be laid on identification of new targets and vaccination strategies. This book gives a brief glimpse of the epidemiology of leishmaniasis, immune evasion, vaccination, and therapeutic modalities that may work by untangling the immunological cross-wires of pathogenic cross-talk. The Conventional treatment and its drawbacks, the prospects of phytotherapy and nanomedicines, are also discussed. The identification of drug targets with the aim of designing inhibitors is also exemplified. English Leishmaniasis Epidemiology. Leishmaniasis. Medicine Internal Medicine Infectious Diseases Health Sciences 1-78984-101-1 Hemeg, Hassan, editor. Afrin, Farhat, editor. |
language |
English |
format |
eBook |
author |
Hassan Hemeg |
spellingShingle |
Hassan Hemeg Leishmaniases as Re-emerging Diseases / |
author_facet |
Hassan Hemeg Hemeg, Hassan, Afrin, Farhat, |
author_variant |
h h hh |
author2 |
Hemeg, Hassan, Afrin, Farhat, |
author2_variant |
h h hh f a fa |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_sort |
Hassan Hemeg |
title |
Leishmaniases as Re-emerging Diseases / |
title_full |
Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg. |
title_fullStr |
Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg. |
title_full_unstemmed |
Leishmaniases as Re-emerging Diseases / edited by Farhat Afrin and Hassan Hemeg. |
title_auth |
Leishmaniases as Re-emerging Diseases / |
title_new |
Leishmaniases as Re-emerging Diseases / |
title_sort |
leishmaniases as re-emerging diseases / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2018 |
physical |
1 online resource (viii, 222) : illlustrations |
isbn |
1-83881-521-X 1-78984-102-X 1-78984-101-1 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC153 |
callnumber-sort |
RC 3153 L457 42018 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.9364 |
dewey-sort |
3616.9364 |
dewey-raw |
616.9364 |
dewey-search |
616.9364 |
work_keys_str_mv |
AT hassanhemeg leishmaniasesasreemergingdiseases AT hemeghassan leishmaniasesasreemergingdiseases AT afrinfarhat leishmaniasesasreemergingdiseases |
status_str |
n |
ids_txt_mv |
(CKB)4970000000100252 (NjHacI)994970000000100252 (oapen)https://directory.doabooks.org/handle/20.500.12854/51562 (EXLCZ)994970000000100252 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Leishmaniases as Re-emerging Diseases / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796649061619597312 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01128nam a2200325 i 4500</leader><controlfield tag="001">993545327804498</controlfield><controlfield tag="005">20221013103448.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221013s2018 enka ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83881-521-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-78984-102-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000100252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000100252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/51562</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000100252</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC153</subfield><subfield code="b">.L457 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.9364</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hassan Hemeg</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Leishmaniases as Re-emerging Diseases /</subfield><subfield code="c">edited by Farhat Afrin and Hassan Hemeg.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2018</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, United Kingdom :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (viii, 222) :</subfield><subfield code="b">illlustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (Intech, viewed October 13, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furthermore, to strengthen the leishmaniasis elimination drive, particular emphasis has to be laid on identification of new targets and vaccination strategies. This book gives a brief glimpse of the epidemiology of leishmaniasis, immune evasion, vaccination, and therapeutic modalities that may work by untangling the immunological cross-wires of pathogenic cross-talk. The Conventional treatment and its drawbacks, the prospects of phytotherapy and nanomedicines, are also discussed. The identification of drug targets with the aim of designing inhibitors is also exemplified.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Leishmaniasis</subfield><subfield code="x">Epidemiology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Leishmaniasis.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-78984-101-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hemeg, Hassan,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Afrin, Farhat,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:02:10 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351645710004498&Force_direct=true</subfield><subfield code="Z">5351645710004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351645710004498</subfield></datafield></record></collection> |